OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
- Conditions
- Irritability Associated With Autism Spectrum Disorder (ASD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2023-08-14
- Target Recruit Count
- 119
- Registration Number
- NCT04174365
- Locations
- 🇺🇸
For additional information regarding sites, Princeton, New Jersey, United States
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2024-07-25
- Target Recruit Count
- 450
- Registration Number
- NCT04124614
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, San Diego, California, United States
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
- First Posted Date
- 2019-10-04
- Last Posted Date
- 2024-06-28
- Target Recruit Count
- 475
- Registration Number
- NCT04115319
- Locations
- 🇷🇴
Spitalul Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia", Sectia Psihiatrie XII, Bucuresti, Romania
🇷🇺Saint Petersburg State Budgetary Institution of Healthcare "Psychoneurological Dispensay No 1", Saint Petersburg, Russian Federation
🇷🇺State Budgetary Institution of Healthcare of Stavropol territory "Regional Specialization Psychiatry Hospital # 2", Stavropol, Russian Federation
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 463
- Registration Number
- NCT04109950
- Locations
- 🇺🇦
Research Site, Vinnytsia, Ukraine
A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
- Conditions
- Borderline Personality Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2019-09-24
- Last Posted Date
- 2024-07-18
- Target Recruit Count
- 332
- Registration Number
- NCT04100096
- Locations
- 🇺🇸
Institute of Living Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Mindful Behavioral Health, Boca Raton, Florida, United States
🇺🇸University of Connecticut, Farmington, Connecticut, United States
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2024-06-26
- Target Recruit Count
- 464
- Registration Number
- NCT04092686
- Locations
- 🇺🇸
Arch Clinical Trials, LLC, Saint Louis, Missouri, United States
🇧🇬Mental Health Centre, Prof. Dr. Ivan Temkov, Burgas EOOD, Department for Treatment of Emergency Psychiatric Conditions, Burgas, Bulgaria
🇧🇬State Psychiatric Hospital Sv. Ivan rilski-Department General Psychiatry for Adults "closed" Type -Men, Department General Psychiatry for Adults, "Closed" Type - Women, Novi Iskar, Bulgaria
Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2023-01-13
- Target Recruit Count
- 13
- Registration Number
- NCT04081363
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, New York, New York, United States
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-06-26
- Target Recruit Count
- 463
- Registration Number
- NCT04072354
- Locations
- 🇺🇦
Dr. Vladyslav Demchenko, Kyiv, Ukraine
🇺🇸Advanced Research Center, Inc., Anaheim, California, United States
🇺🇸Advanced Discovery Research LLC, Atlanta, Georgia, United States
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 22
- Registration Number
- NCT04038957
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2023-11-18
- Target Recruit Count
- 266
- Registration Number
- NCT04030143
- Locations
- 🇺🇸
NRC Research Institute, Orange, California, United States
🇺🇸California Clinical Trials Medical Group, Glendale, California, United States
🇺🇸Woodland International Research Group, Rogers, Arkansas, United States